Evaluating Management and Change in Glycemic Control After Discontinuation of Metformin in Patients With Elevated Serum Creatinine.
Year: 2017
Type: article
Abstract: Recently revised FDA labeling allows many patients with mild-to-moderate kidney disease to benefit from treatment with metformin.
Source: Europe PMC (PubMed Central)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3024738670
